Alexander Stevenson
Founder chez 4D PHARMA PLC
Fortune : 59 112 $ au 31/03/2024
Profil
Alexander James Stevenson is the founder of Modern Biosciences Ltd.
(founded in 2006) and 4D Pharma Plc (founded in 2014).
He held the title of Chief Operating Officer at Modern Biosciences Ltd.
from 2006 to 2008.
Currently, Dr. Stevenson is a Director at Aquarius Equity Partners Ltd., C4X Discovery Ltd., North West Seed Fund General Partner Ltd., Aquarius Origin Fund Managing Member Ltd., Aquarius Northern Entrepreneurs Managing Member Ltd., Aquarius Equity Director Ltd., Aquarius IV Fund Managing Member Ltd., Aquarius Life Science Ltd., Schosween 18 Ltd., The Microbiota Co. Ltd., and C4X Discovery Holdings Plc.
He also held the position of Chief Executive Officer at Avacta Group Plc and Director at GT Biologics Ltd., Aquarius Equity Holdings Ltd., and Zogenix International Ltd.
Dr. Stevenson's former positions include Non-Executive Director at Tissue Regenix Group Plc from 2007 to 2013.
He received his undergraduate, MBA, and doctorate degrees from the University of Leeds.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/07/2023 | 485 403 ( 0,19% ) | 59 112 $ | 31/03/2024 |
Postes actifs de Alexander Stevenson
| Sociétés | Poste | Début |
|---|---|---|
| 4D PHARMA PLC | Founder | 18/02/2014 |
| C4X DISCOVERY HOLDINGS PLC | Director/Board Member | 03/09/2014 |
Aquarius Equity Partners Ltd.
 Aquarius Equity Partners Ltd. Investment ManagersFinance Aquarius Equity Partners Ltd is an independent private equity firm founded in the year 2002 by Alan John Aubrey and Duncan Joseph Peyton headquarters in the UK. | Private Equity Investor | 01/01/2008 |
| Aquarius IV Fund Managing Member Ltd. | Director/Board Member | - |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Director/Board Member | - |
| Schosween 18 Ltd. | Director/Board Member | - |
The Microbiota Co. Ltd.
 The Microbiota Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of 4D Pharma Plc, The Microbiota Co. Ltd. develops a patented bacteria which treats irritable bowel syndrome and related symptoms. The private company is based in Manchester, UK. The Microbiota Co. was acquired by 4D Pharma Plc on July 18, 2014 for $1.65 million. | Director/Board Member | - |
| North West Seed Fund General Partner Ltd. | Director/Board Member | - |
| Aquarius Life Science Ltd. | Director/Board Member | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Alexander Stevenson
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ | - |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Alexander Stevenson
| University of Leeds | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| TISSUE REGENIX GROUP PLC | Health Technology |
| 4D PHARMA PLC | Health Technology |
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| Entreprise privées | 14 |
|---|---|
Modern Biosciences Ltd.
 Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Health Technology |
Aquarius Equity Partners Ltd.
Aquarius Equity Partners Ltd. Investment ManagersFinance Aquarius Equity Partners Ltd is an independent private equity firm founded in the year 2002 by Alan John Aubrey and Duncan Joseph Peyton headquarters in the UK. | Finance |
GT Biologics Ltd.
 GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology GT Biologics Ltd. manufactures and distributes pharmaceutical products. It develops and commercializes an oral-based probiotic product for the treatment of mild to moderate Crohn's disease and ulcerative colitis and a novel family of protein, peptide therapeutics for the treatment of moderate to severe inflammatory bowel diseases. The company was founded by Denise Kelly in 2008 and is headquartered in Leeds, the United Kingdom. | Health Technology |
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
| North West Seed Fund General Partner Ltd. | |
| Aquarius Origin Fund Managing Member Ltd. | |
Aquarius Equity Holdings Ltd.
 Aquarius Equity Holdings Ltd. Financial ConglomeratesFinance Aquarius Equity Holdings Ltd. functions as an investment holding British company. The private company is based in Manchester, UK. and has subsidiaries in United Kingdom. | Finance |
| Aquarius Northern Entrepreneurs Managing Member Ltd. | |
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
| Aquarius Equity Director Ltd. | |
| Aquarius IV Fund Managing Member Ltd. | |
| Aquarius Life Science Ltd. | |
| Schosween 18 Ltd. | |
The Microbiota Co. Ltd.
The Microbiota Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of 4D Pharma Plc, The Microbiota Co. Ltd. develops a patented bacteria which treats irritable bowel syndrome and related symptoms. The private company is based in Manchester, UK. The Microbiota Co. was acquired by 4D Pharma Plc on July 18, 2014 for $1.65 million. | Health Technology |
